|
 |
| ORIGINAL ARTICLE |
|
| Year : 2012 | Volume
: 3
| Issue : 1 | Page : 57-61 |
|
|
Design, synthesis, and antimicrobial screening of novel pyridyl-2-amidrazone incorporated isatin mannich bases
N Saravana Kumar1, T Pradeep1, G Jani1, Divya Silpa1, B Vijaya Kumar2
1 Department of Pharmaceutical Chemistry, Sasikanth Reddy College of Pharmacy, North Rajupalem, Nellore, India
2 Department of Pharmaceutical Chemistry, Sri Venkateswara College of Pharmacy, R.V. S. Nagar, Chittoor, Andhra Pradesh, India
| Date of Web Publication | 6-Mar-2012 |
Correspondence Address:
N Saravana Kumar
Department of Pharmaceutical Chemistry, Sasikanth Reddy College of Pharmacy, North Rajupalem, Nellore - 524 316, Andhra Pradesh
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2231-4040.93559
 Abstract | | |
Isatin is an endogenous compound and reported to possess a wide range of biological activities. Numerous papers have shown that the pyridyl-2-amidrazone nucleus possesses a potent antimicrobial activity . Based on these prior observations, we postulated that a compound containing both isatin and pyridyl-2-amidrazone pharmacophores could be very effective for antimicrobial activity. Unfavorable adsorption, distribution, metabolism, and excretion (ADME) properties can in many cases lead to the clinical trials failure of potentially successful drug candidates. Their evaluation, therefore, at an earlier stage is desired. Here, we also present the predicted ADME properties of our ligands through computation. All the compounds (2a1 - 5 ) exhibited a better solubility, diffusion, Log P, molecular weight, etc., with no violations making the ligands pharmacodynamically active and better oral absorptive series. Based on the results of computational design, a series of novel pyridyl-2-amidrazone-incorporated isatin Mannich bases were synthesized and screened for their antimicrobial activities. IR, 1 H-NMR, and Mass Spectroscopy data were consistent with the assigned structures. The results exhibited that all of the lead compounds showed good antimicrobial activities; noticeably, the compound 2a 2 showed the best activity against Candida albicans (16 μ g/ml) and compound 2a 3 was found to be the most active derivative against Staphylococcus aureus and Escherichia coli at minimal inhibitory concentration values of 4 and 32 μ g/ml, respectively. Keywords: Antimicrobial activity, isatin, Lipinski′s rule of 5, pyridyl-2-amidrazone
How to cite this article:
Kumar N S, Pradeep T, Jani G, Silpa D, Kumar B V. Design, synthesis, and antimicrobial screening of novel pyridyl-2-amidrazone incorporated isatin mannich bases. J Adv Pharm Technol Res 2012;3:57-61 |
How to cite this URL:
Kumar N S, Pradeep T, Jani G, Silpa D, Kumar B V. Design, synthesis, and antimicrobial screening of novel pyridyl-2-amidrazone incorporated isatin mannich bases. J Adv Pharm Technol Res [serial online] 2012 [cited 2023 Mar 27];3:57-61. Available from: https://www.japtr.org/text.asp?2012/3/1/57/93559 |
| Introduction | |  |
Isatin is an endogenous compound isolated in 1988 [1] and reported to possess a wide range of biological activities. [2],[3] Owing to these properties, derivatives of isatin have been developed for therapeutic applications. A recent example is the compound SU11248 (Sutent), a 5-fluoro-3-substituted-2-oxoindole that has received FDA approval for the treatment of gastrointestinal stromal tumors [4] and advanced renal cell carcinoma. [5] Isatin is the biologically active chemical produced by an Alteromonas sp. strain inhabiting the surface of embryos of the caridean shrimp Palaemon macrodactylus, which protects them from the pathogenic fungus Lagenidium callinectes.[6] Schiff bases and Mannich bases of isatin were reported to possess antibacterial, [7],[8],[9] antifungal, [10],[11],[12] antiviral, [13],[14],[15] anti-HIV, [16],[17],[18] antiprotozoal, [19],[20] analgesic, [21] and antihelminthic [22],[23] activities. Rapid development of resistance to clinically important Gram-positive bacteria is a serious public health threat. Staphylococcus aureus can produce a number of diseases affecting human beings and animals. Therefore, the search for novel bactericidal compounds is the object of continuous investigation. [24],[25],[26],[27],[28],[29],[30]
Numerous papers have shown that the pyridyl-2-amidrazone nucleus possesses a potent antimicrobial activity. [31],[32],[33],[34]
Based on these prior observations, we postulated that a compound containing both isatin and pyridyl-2-amidrazone pharmacophores could be very effective for antimicrobial activity. The synthesis of isatin - pyridyl-2-amidrazone conjugates could be possible by a pharmacophore hybrid approach. Hybridization of two different bioactive molecules with complementary pharmacophoric functions or with different mechanisms of action often showed synergistic effects. [35],[36],[37],[38],[39] Therefore, we synthesized hybrid compounds by linking the main structural unit of the isatin ring system with the pyridyl-2-amidrazone ring system by a Schiff base reaction [Figure 1]. Furthermore, a new series of the corresponding N-Mannich bases was synthesized by reacting them with formaldehyde and various secondary amines and then examined their antimicrobial activities. | Figure 1: A design for synthesis of isatin-pyridyl-2-amidrazone analogs (2a1– 5)
Click here to view |
Unfavorable adsorption, distribution, metabolism, and excretion (ADME) properties can in many cases lead to the clinical trials failure of potentially successful drug candidates. Analysis of the structures of orally administered drugs, and of drug candidates, as pioneered by Lipinski in 1995, [40] has so far been the primary guide to correlating physical properties with successful drug development. [41],[42] This analysis has been very useful and has led to a set of rules relating to the importance of lipophilicity (octanol-water partition), molecular weight (MW), and the number of hydrogen bond donors and acceptors.
This analysis led to the "Rule of Five" mnemonic. The name of this mnemonic refers to the observation that all the critical threshold values are multiples of five. The "Rule of Five" states that poor absorption is more likely when a compound possesses:
- more than five H-bond donors
- more than ten H-bond acceptors
- ClogP greater than five (or MlogP greater than 4.15)
- molecular mass over 500 Da
Their evaluation, therefore, at an earlier stage is desired. Here, we also present the predicted ADME properties of our inhibitors calculated using the Molinspiration online server which estimates both physically significant descriptors and pharmaceutically relevant properties.
| Materials and Methods | | |
All the melting points were taken with the help of an open capillary tube and were uncorrected . The structures of prepared compounds were identified on the basis of their IR, 1 H-NMR, and mass spectra. The IR spectra (KBr) were recorded using JASCO FTIR-420 Series of department of Pharmaceutical Analysis, Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore. 1 H-NMR spectra were recorded using a Bruker advance 500 MHz NMR Spectrometer of Sophisticated Analytical Instrument Facility department, IIT, Chennai. Mass spectra were recorded on The JEOL GCMATE II GC-MS, The Sophisticated Analytical Instruments Facility (SAIF), Department of Science and Technology (DST), IIT, Chennai. Reactions were monitored by thin-layer chromatography on a precoated silica gel G plates using Iodine vapors as visualizing agent. Pharmacological Evaluation was done in the Department of Pharmaceutical Chemistry, Sasikanth Reddy College of Pharmacy, Nellore, India. IR, 1 H-NMR, Mass Spectroscopy, and elemental analysis were consistent with the assigned structures.
Adsorption, Distribution, Metabolism, and Excretion Property Prediction
Lipinski screening test
Results from the Molinspiration ADME predictions are presented in [Table 1]. To test the drug-likeness of the ligands, we applied Lipinski's rule of 5, requiring candidates to have no more than 5 and 10 hydrogen bond donors and acceptors, respectively, MW less than 500 amu, and partition coefficients between octanol and water (QPlog P(oct/wat)) less than 5. An orally active compound/drug should have no more than one violation of these rules. All the test compounds with the violation of '0' passed the Lipinski screening test. Poor absorption or permeation is more likely when a ligand molecule violates Lipinski's rule of 5.
General methods of synthesis
In the present study, isatin is treated with the pyridyl-2-amidrazone [43] to form Schiff base (1). Then, this intermediate undergoes reaction in presence of formaldehyde and various secondary amines to form N-Mannich Bases of isatin (2a 1 -2a 5 ) as depicted in the [Figure 2]. All the synthesized compounds are soluble in dimethylformamide.
General procedure for the synthesis of N-{[2-oxo-1H-indol-3- ylidene] amino} pyridine-2-carboximidamide (1)
Indoline-2,3-dione (Isatin) (1.0 mmol) was dissolved in methanol (5 ml) with gentle heating, then pyridyl-2-amidrazone (2.4 mmol) was slowly added with stirring at room temperature. After stirring overnight, the resulting precipitate was filtered and crystallized or the reaction mixture was evaporated to dryness and the residue suitably purified.
General procedure for the synthesis of N-{[1-[(dimethylamino) methyl]-2-oxo-1H-indol-3-ylidene]amino}pyridine-2-carboximidamide (2a 2 )
To a solution of dimethylamine (0.02 mol) in ethanol (50 ml), isatin and its derivatives (0.02 mol) and 37% formalin (1 ml) were added. The reaction mixture was heated under reflux for 24 hours. On cooling, the precipitate was collected, washed with cold ethanol, and recrystallized from a mixture of DMF and water to give 2a 2 . In an analogous way, the remaining drug molecules 2a 1 , 2a 3 , 2a 4 , and 2a 5 have been prepared.
Antimicrobial screening
We have designed and synthesized novel pyridyl-2-amidrazone incorporated isatin mannich bases, in order to investigate their antimicrobial activity. The compounds (2a 1-5 ) were tested for antimicrobial activity against Staphylococcus aureus,, Escherichia More Details coli, and Candida albicans. The minimal inhibitory concentration (MIC) of the synthesized compounds was determined against S. aureus, E. coil, and C. albicans using a standard broth dilution technique. All the MIC results are presented in [Table 2].
| Results and Discussion | | |
Chemistry
IR, 1 H-NMR, Mass Spectroscopy, and elemental analysis were consistent with the assigned structures.
N'-[2-oxo-1,2-dihydro-3H-indol-3-ylidene]pyridine-2-carboximidohydrazide [2a 1 ]
Percent yield: 66.22% (solid). Mp. 203°C. FTIR (KBr): cm -1 3438 (N-H Stretch); 3058 (Ar C-H Stretch); 1686 (C = 0 Stretch); 1488 (C = N Stretch); 3390 (imines N-H Stretch); 1096 (N-N Stretch); 1 H-NMR (DMSO, d ppm); 7.92-8.43 (s, 1H, NH-CO). 1.62 (s, 1H, -NH); 7.0-8.6 (m, 8H, Ar-H), 7.07 (s, 1H, NH), MS mlz 266 [M+1]. Anal Calcd for C 14 H 11 N 5 O: C, 63.39; H, 4.18; N, 26.40; O, 6.03. Found: C, 63.41; H, 4.20; N, 26.43; O, 6.04.
N'-{1-[(dimethylamino)methyl]-2-oxo-1,2-dihydro-3H-indol-3-ylidene}pyridine-2-carboximidohydrazide [2a 2 ]
Percent yield: 73 % (solid). Mp. 218°C. FTIR (KBr): cm -1 3045 (Ar C-H Stretch); 1785 (C = 0 Stretch); 1613 (C = N Stretch); 3381 (imines N-H Stretch); 1465 (-CH 2 -), 1072 (N-N Stretch); 1 H-NMR (DMSO, d ppm); 2.27 (s, 6H, -N (CH3) 2 ), 7.0-8.6 (m, 8H, Ar-H), 4.03 (s, 2H, -NCH 2 N-), 7.0 (s, 1H, NH), MS mlz 323 [M+1]. Anal Calcd for C 17 H 18 N 6 O: C, 63.34; H, 5.63; N, 26.07; O, 4.96. Found: C, 63.38; H, 5.61; N, 26.11; O, 4.97.
N'-{1-[(diethylamino)methyl]-2-oxo-1,2-dihydro-3H-indol-3-ylidene}pyridine-2-carboximidohydrazide [2a 3 ]
Percent yield: 69.72% (solid). Mp. 209°C. FTIR (KBr): cm -1 3041 (Ar C-H Stretch); 1772 (C = 0 Stretch); 1604 (C = N Stretch); 3374 (imines N-H Stretch); 1441 (-CH 2 -), 1059 (N-N Stretch); 1 H-NMR (DMSO, d ppm); 1.50-2.24 (q, 4H, -N (C 2 H 5 ) 2 ), 7.0-8.6 (m, 8H, Ar-H), 4.03 (s, 2H, -NCH 2 N-), 7.02 (s, 1H, NH), MS mlz 352 [M+1]. Anal Calcd for C 19 H 22 N 6 O: C, 65.12; H, 6.33; N, 23.98; O, 4.57. Found: C, 65.15; H, 6.35; N, 23.97; O, 4.55.
N'-[2-oxo-1-(piperidin-1-ylmethyl)-1,2-dihydro-3H-indol-3-ylidene]pyridine-2-carboximidohydrazide [2a 4 ]
Percent yield: 71.54% (solid). Mp. 252°C. FTIR (KBr): cm -1 3049 (Ar C-H Stretch); 1745 (C = 0 Stretch); 1645 (C = N Stretch); 3367 (imines N-H Stretch); 1434 (-CH 2 -), 1063 (N-N Stretch); 1 H-NMR (DMSO, d ppm); 1.50-2.24 (s, 4H, CH 2 Piperidinyl), 7.0-8.6 (m, 8H, Ar-H), 4.03 (s, 2H, -NCH 2 N-), 7.0 (s, 1H, NH), MS mlz 363 [M+1]. Anal Calcd for C 20 H 22 N 6 O: C, 66.28; H, 6.12; N, 23.19; O, 4.41. Found: C, 66.26; H, 6.14; N, 23.19; O, 4.43.
N'-[1-(morpholin-4-ylmethyl)-2-oxo-1,2-dihydro-3H-indol-3-ylidene]pyridine-2-carboximidohydrazide [2a 5 ]
Percent yield: 82.14% (solid). Mp. 243°C. FTIR (KBr): cm -1 3037 (Ar C-H Stretch); 1751(C = 0 Stretch); 1639 (C = N Stretch); 3358 (imines N-H Stretch); 1443 (-CH 2 -), 1067 (N-N Stretch); 1 H-NMR (DMSO, d ppm); 2.37-3.67 (m, 4H, CH 2 morpholinyl), 7.0-8.6 (m, 8H, Ar-H), 4.43 (s, 2H, -NCH 2 N-), 7.0 (s, 1H, NH), MS mlz 365 [M+1]. Anal Calcd for C 19 H 20 N 6 O 2 : C, 62.62; H, 5.53; N, 23.06; O, 8.78. Found: C, 62.61; H, 5.55; N, 23.08; O, 8.79.
Antimicrobial Screening
Antibacterial screening
The investigation of antibacterial screening [Table 2] revealed that all the newly synthesized compounds were able to inhibit the growth of the selected microorganisms in vitro showing MIC values between 4 and 256 μ g/ml. Among the synthesized compounds, 2a 3 was found to be the most active derivative against S. aureus and E. coli at MIC values of 4 and 32 μ g/ml, respectively. But the compounds 2a 2 showed a good activity with MICs of 32 μ g/ml. Also, the other compounds exhibited moderate activity against the test microorganisms.
Antifungal screening
The investigation of antifungal screening [Table 2] revealed that all the newly synthesized compounds were able to inhibit the growth of the selected microorganisms in vitro showing MIC values between 4 and 256 μ g/ml. Among the synthesized compounds, 2a 2 showed the best activity against C. albicans (16 μ g/ml). But the compound 2a 1 also showed a good activity with MICs of 32 mg/ml. Also, the other compounds exhibited moderate activity against the test microorganisms.
| Conclusion | | |
It has been very clear from the above findings that the heterocyclic compounds containing both isatin and pyridyl-2-amidrazone rings have pharmacological activities as predicted. The design, synthesis, and biological screening had shown that among the compounds synthesized, the compound 2a 3 and 2a 2 can be a lead for the antibacterial and antifungal design, respectively, and further derivatives can be prepared with modification of these particular moieties.
| References | | |
| 1. | Glover V, Halket JM, Watkins PJ, Clow A, Goodwin BL, Sandier M. Isatin: Identity with the purified endogenous monoamine oxidase inhibitor tribulin. J Neurochem 1988;51:656-60. 
|
| 2. | Pandeya SN, Smitha S, Jyoti M, Sridhar SK. Biological activities of isatin and its derivatives. Acta Pharm 2005;55:27-46.
|
| 3. | Teeyapant R, Woerdenbag HJ, Kreis P, Hacker J, Wray V, Witte L, et al. Antibiotic and cytotoxic activity of brominated compounds from the marine sponge Verongia aerophoba. Z Naturforsch C 1993;48:939-45.
|
| 4. | Prenen H, Cools J, Mentens N, Folens C, Sciot R, Schöffski P, et al. Efficacy of the kinase inhibitor SU11248 against gastrointestinal stromal tumor mutants refractory to imatinib mesylate. Clin Cancer Res 2006;12:2622-7.
|
| 5. | Motzer RJ, Michaelson MD, Redman BG, Hudes GR, Wilding G, Figlin RA, et al. Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma. J Clin Oncol 2006; 24:16-24.
|
| 6. | Gil-Turnes MS, Hay ME, Fenical W. Symbiotic marine bacteria chemically defend crustacean embryos from a pathogenic fungus. Science 1989; 246:116-8.
|
| 7. | Pandeya SN, Sriram D. Synthesis and screening for antibacterial activity of Schiff's and Mannich bases of Isatin and its derivatives. Acta Pharm Turc 1998;40:33-8.
|
| 8. | Sarangapani M, Reddy VM. Pharmacological evaluation of 1-(N,N-disubstituted aminomethyl)-3-imino-(2-phenyl-3,4-dihydro-4-oxo-quinazolin-3-yl) indolin-2-ones. Indian J Pharm Sci 1994;56:174-7.
|
| 9. | Varma RS, Nobles WL. Antiviral, antibacterial, and antifungal activities of isatin N-Mannich bases. J Pharm Sci 1975;64:881-2.
|
| 10. | Pandeya SN, Sriram D, Nath G, De Clercq E. Synthesis antibacterial, antifungal and anti HIV activity of Schiff's and Mannich bases of isatin with N-[6-Chlorobenz thiazole-2-yl]thiosemicarbazide. Indian J Pharm Sci 1999;61:358-61.
 |
| 11. | Pandeya SN, Sriram D, Nath G, De Clercq E. Synthesis, antibacterial, antifungal and anti-HIV evaluation of Norfloxacin Mannich bases. Sci Pharm 1999;67:103-11.
|
| 12. | Pandeya SN, Sriram D, Nath G, De Clercq E. Synthesis, antibacterial, antifungal and anti-HIV evaluation of Schiff and Mannich bases of isatin derivatives with 3-amino-2-methyl mercapto quinazolin - 4(3H)- one. Pharm Acta Helv 1999;67:11-7.
|
| 13. | Varma RS, Nobles WL. Synthesis and antiviral and antibacterial activity of certain Ndialkylaminomethylisatin beta-thiosemicarbazones. J Med Chem 1967;10:972-4.
|
| 14. | Singh SP, Shukla SK, Awasthi LP. Synthesis of some 3-(4′ -nitrobenzoylhydrazono)-2- indolinones as a potential antiviral agents. Curr Sci 1983;52:766-9.
|
| 15. | Logan JC, Fox MP, Morgan JH, Makohon AM, Pfau CJ. Arenavirus inactivation on contact with N-substituted isatin â-thiosemicarbazones and certain cations. J Gen Virol 1975;28:271-83.
|
| 16. | Pandeya SN, Yogeeswari P, Sriram D, De Clercq E, Pannecouque C, Witvrouw M. Synthesis and screening for anti-HIV activity of some N-Mannich bases of isatin derivatives. Chemotherapy 1999;45:192-6.
|
| 17. | Pandeya SN, Sriram D, Nath G, De Clercq E. Synthesis, antibacterial, antifungal and anti- HIV activities of Norfloxacin Mannich bases. Eur J Med Chem 2000;35:249-55.
|
| 18. | Pandeya SN, Sriram D, Nath G, De Clercq E. Synthesis, antibacterial, antifungal and anti- HIV evaluation of Schiff and Mannich bases of isatin and its derivatives with triazole. Arzneim Forsch Drug Res 2000;50:55-9.
|
| 19. | Imam SA, Varma RS. Isatin-3-anils as excystment and cysticidal agents against Schizopyrenus russelli. Experientia 1975;31:1287-8.
|
| 20. | Varma RS, Khan IA. Potential biologically active agents. X. Synthesis of 3-arylimino-2-indolinones, and their 1-methyl- and 1-morpholino/piperidinomethyl derivatives as excystment and cysticidal agents against Schizopyrenus russelli. Pol J Pharmacol Pharm 1977;29:549-94.
|
| 21. | Prakash CR, Raja S, Saravanan G. Synthesis, characterization, and analgesic activity of novel Schiff base of isatin derivatives. J Adv Pharm Tech Res 2010;1:342-7.
|
| 22. | Sarciron ME, Audin P, Delebre I, Gabrion C, Petavy AF, Paris J. Synthesis of propargylic alcohols and biological effects on Echinococcus multilocularis metacestodes. J Pharm Sci 1993;82:605-9.
|
| 23. | El-Sawi EA, Mostaza TB, Mostaza BB. Studies on the molluscicidal action of some isatin derivatives against Biomphalaria alexandrina in Egypt. J Egypt Soc Parasitol 1998;28:481-6.
|
| 24. | Nielsen SF, Boesen T, Larsen M, Schonning K, Kromann H. Antibacterial chalcones - bioisosteric replacement of the 4'-hydroxy group. Bioorg Med Chem 2004;12:3047-54.
|
| 25. | Tsukiyama R, Katsura H, Tokuriki N, Kobayashi M. Antibacterial activity of licochalcone A against spore-forming bacteria. Antimicrob Agents Chemother 2002;46:1226-30.
|
| 26. | Nielsen SF, Larsen M, Boesen T, Schonning K, Kromann H. Cationic chalcone antibiotics. Design, synthesis, and mechanism of action. J Med Chem 2005;48:2667-77.
|
| 27. | Haraguchi H, Tanimoto K, Tamura Y, Mizutani K, Kinoshita T. Mode of antibacterial action of retrochalcones from Glycyrrhiza inflate. Phytochemistry 1998;48:125-9.
|
| 28. | Lopez SN, Castelli MV, Zacchino SA, Domínguez JN, Lobo G, Charris-Charris J, et al. In vitro antifungal evaluation and structure-activity relationships of a new series of chalcone derivatives and synthetic analogues, with inhibitory properties against polymers of the fungal cell wall. Bioorg Med Chem 2001;9:1999-2013.
|
| 29. | Boeck P, Leal PC, Yunes RA, Filho VC, López S, Sortino M, et al. Antifungal activity and studies on mode of action of novel xanthoxyline-derived chalcones. Arch Pharm (Weinhein) 2005;338:87-95.
|
| 30. | Svetaz L, Tapia A, Lopez SN, Furlan RL, Petenatti E, Pioli R, et al. Antifungal chalcones and new caffeic acid esters from Zuccagnia punctata acting against soyabean infecting fungi. J Agric Food Chem 2004;52:3297-300.
|
| 31. | Mamolo MG, Falagiani V, Vio L, Banfi E. Synthesis and antimycobacterial activity of some N 1 -[1-[3-aryl-1-(pyridin-2-, 3-, or 4-yl)-3-oxo] propyl]-2-pyridinecarboxamidrazones. Farmaco 1999;54:761-7.
|
| 32. | Modzelewska-Banachiewicz B, Matysiak J, Niewiadomy A. Synthesis and mycological activity of the compounds obtained in the reaction of N(3)-substituted amidrazones with sulphinyl-bis-2,4-dihydroxybenzenethioyl. Eur J Med Chem 2001;36:75-80.
|
| 33. | Banfi E, Mamolo MG, Zampieri D, Vio L, Monti Bragadin C. Antimycobacterial activity of N1-{1-[3-aryl-1-(pyridin-2-, 3- or 4-yl)-3-oxo] propyl}-2-pyridinecarboxamidrazones. J Antimicrob Chemother 2001;48:705-7.
|
| 34. | Mamolo MG, Zampieri D, Falagiani V, Vio L, Fermeglia M, Ferrone M, et al. Antifungal and antimycobacterial activity of new N 1 -[1-aryl-2-(1Himidazol-1-yl and 1H-1,2,4-triazol-1-yl)-ethylidene]-pyridine-2-carboxamidrazone derivatives: A combined experimental and computational approach. ARKIVOC 2004;(part v):231-50.
|
| 35. | Romagnoli R, Baraldi PG, Carrion MD, Cruz-Lopez O, Preti D, Tabrizi MA, et al. Hybrid molecules containing benzo[4,5]imidazo[1,2-d][1,2,4]thiadiazole and alpha-bromoacryloyl moieties as potent apoptosis inducers on human myeloid leukaemia cells. Bioorg Med Chem Lett 2007;17:2844-8.
|
| 36. | Romagnoli R, Baraldi PG, Carrion MD, Cruz-Lopez O, Cara CL, Balzarini J, et al. Hybrid alpha-bromoacryloylamido chalcones. Design, synthesis and biological evaluation. Bioorg Med Chem Lett 2009;19:2022-8.
|
| 37. | Meunier B. Hybrid molecules with a dual mode of action: dream or reality? Acc Chem Res 2008;41:69-77.
|
| 38. | Kamal A, Khan MN, Reddy KS, Srikanth YV, Sridhar B. Synthesis, Structural characterization and biological evaluation of novel [1,2,4]triazolo [1,5-b][1,2,4]benzothiadiazine-benzothiazole conjugates as potential anticancer agents. Chem Biol Drug Des 2008;71:78-86.
|
| 39. | Kamal A, Khan MN, Reddy KS, Ahmed SK, Kumar MS, Juvekar A, et al. 1,2,4-Benzothiadiazine linked pyrrolo[2,1-c][1,4]benzodiazepine conjugates: Synthesis, DNA-binding affinity and cytotoxicity. Bioorg Med Chem Lett 2007;17:5345-8.
|
| 40. | Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 1997;23:3-25.
|
| 41. | Lipinski CA. Annual Meeting of the American Association of Pharmaceutical Scientists; Biotech/PDD Symposium on Tools for Oral Absorption, 1995.
|
| 42. | Lipinski CA. Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods 2000;44:235-49.
|
| 43. | Francis H. Case, The Preparation of hydrazidines and as-triazines related to substituted 2-Cyanopyridines. J Org Chem 1965;30:931.
|
[Figure 1], [Figure 2]
[Table 1], [Table 2]
|
